Citrullus lanatus 'sentinel' (watermelon) extract reduces atherosclerosis in LDL receptor-deficient mice

Journal of Nutritional Biochemistry

Volumn 24, Issue 5, 2013, Pages 882-886

  Poduri, Aruna ^a   Rateri, Debra L ^a   Saha, Shubin K ^a   Saha, Sibu ^b   Daugherty, Alan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Cholesterol; Citrullus lanatus; LDL receptor deficient mice

Indexed keywords

CITRULLINE; CITRULLUS LANATUS EXTRACT; GAMMA INTERFERON; INTERLEUKIN 10; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG BLOOD LEVEL; DRUG MECHANISM; FAT MASS; FLUID INTAKE; FOOD INTAKE; HYPERCHOLESTEROLEMIA; LIPID DIET; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; THORACIC AORTA; URINE VOLUME; WATERMELON; WEIGHT REDUCTION;

ANIMALS; AORTA, THORACIC; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY WEIGHT; CHEMOKINE CCL2; CHOLESTEROL, LDL; CITRULLINE; CITRULLUS; HYPERCHOLESTEROLEMIA; INTERFERON-GAMMA; INTERLEUKIN-10; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, KNOCKOUT; PLANT EXTRACTS; RECEPTORS, LDL;

CITRULLUS LANATUS; CITRULLUS LANATUS VAR. LANATUS; MUS;

EID: 84876811462     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.05.011     Document Type: Article

References (34)

1. Stampfer M.J., Hu F.B., Manson J.E., Rimm E.B., Willett W.C. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000, 343:16-22.
2. Chiuve S.E., McCullough M.L., Sacks F.M., Rimm E.B. Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications. Circulation 2006, 114:160-167.
3. Hu F.B. Diet and lifestyle influences on risk of coronary heart disease. Curr Atheroscler Rep 2009, 11:257-263.
4. Vinson J.A., Liang X., Proch J., Hontz B.A., Dancel J., Sandone N. Polyphenol antioxidants in citrus juices: in vitro and in vivo studies relevant to heart disease. Adv Exp Med Biol 2002, 505:113-122.
5. Rosenblat M., Volkova N., Coleman R., Aviram M. Pomegranate byproduct administration to apolipoprotein e-deficient mice attenuates atherosclerosis development as a result of decreased macrophage oxidative stress and reduced cellular uptake of oxidized low-density lipoprotein. J Agric Food Chem 2006, 54:1928-1935.
6. Yadav S., Tomar A.K., Jithesh O., Khan M.A., Yadav R.N., Srinivasan A., et al. Purification and partial characterization of low molecular weight vicilin-like glycoprotein from the seeds of Citrullus lanatus. Protein J 2011, 30:575-580.
7. Wani A.A., Sogi D.S., Singh P., Wani I.A., Shivhare U.S. Characterisation and functional properties of watermelon (Citrullus lanatus) seed proteins. J Sci Food Agric 2011, 91:113-121.
8. Wu G., Collins J.K., Perkins-Veazie P., Siddiq M., Dolan K.D., Kelly K.A., et al. Dietary supplementation with watermelon pomace juice enhances arginine availability and ameliorates the metabolic syndrome in Zucker diabetic fatty rats. J Nutr 2007, 137:2680-2685.
9. Altas S., Kizil G., Kizil M., Ketani A., Haris P.I. Protective effect of Diyarbakir watermelon juice on carbon tetrachloride-induced toxicity in rats. Food Chem Toxicol 2011, 49:2433-2438.
10. Figueroa A., Sanchez-Gonzalez M.A., Perkins-Veazie P.M., Arjmandi B.H. Effects of watermelon supplementation on aortic blood pressure and wave reflection in individuals with prehypertension: a pilot study. Am J Hypertens 2011, 24:40-44.
11. Rimando A.M., Perkins-Veazie P.M. Determination of citrulline in watermelon rind. J Chromatogr A 2005, 1078:196-200.
12. Daugherty A. Mouse models of atherosclerosis. Am J Med Sci 2002, 323:3-10.
13. Daugherty A., Rateri D.L., Lu H., Inagami T., Cassis L.A. Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation 2004, 110:3849-3857.
14. Lu H., Rateri D.L., Feldman D.L., Charnigo R.J., Fukamizu A., Ishida J., et al. Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice. J Clin Invest 2008, 118:984-993.
15. Lu H., Wu C., Howatt D.A., Balakrishnan A., Charnigo R.J., Cassis L.A., et al. Differential effects of dietary sodium intake on blood pressure and atherosclerosis in hypercholesterolemic mice. J Nutr Biochem 2012, [in press].
16. Daugherty A., Rateri D.L., Lu H., Balakrishnan A. Measuring blood pressure in mice using volume pressure recording, a tail-cuff method. J Vis Exp 2009, 1291.
17. Napolitano A., Miller S.R., Murgatroyd P.R., Coward W.A., Wright A., Finer N., et al. Validation of a quantitative magnetic resonance method for measuring human body composition. Obesity (Silver Spring) 2008, 16:191-198.
18. Wu G., Meininger C.J. Analysis of citrulline, arginine, and methylarginines using high-performance liquid chromatography. Methods Enzymol 2008, 440:177-189.
19. Wang S., Subramanian V., Lu H., Howatt D.A., Moorleghen J.J., Charnigo R., et al. Deficiency of receptor-associated protein attenuates angiotensin II-induced atherosclerosis in hypercholesterolemic mice without influencing abdominal aortic aneurysms. Atherosclerosis 2012, 220:375-380.
20. Daugherty A., Whitman S.C. Quantification of atherosclerosis in mice. Methods Mol Biol 2003, 209:293-309.
21. Koeners M.P., van Faassen E.E., Wesseling S., de Sain-van der Velden M., Koomans H.A., Braam B., et al. Maternal supplementation with citrulline increases renal nitric oxide in young spontaneously hypertensive rats and has long-term antihypertensive effects. Hypertension 2007, 50:1077-1084.
22. Orozco-Gutierrez J.J., Castillo-Martinez L., Orea-Tejeda A., Vazquez-Diaz O., Valdespino-Trejo A., Narvaez-David R., et al. Effect of l-arginine or l-citrulline oral supplementation on blood pressure and right ventricular function in heart failure patients with preserved ejection fraction. Cardiol J 2010, 17:612-618.
23. Smith H.A., Canter J.A., Christian K.G., Drinkwater D.C., Scholl F.G., Christman B.W., et al. Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline. J Thorac Cardiovasc Surg 2006, 132:58-65.
24. Beddhu S. The body mass index paradox and an obesity, inflammation, and atherosclerosis syndrome in chronic kidney disease. Semin Dial 2004, 17:229-232.
25. Kerkhof G.F., Duivenvoorden H.J., Leunissen R.W., Hokken-Koelega A.C. Pathways leading to atherosclerosis: a structural equation modeling approach in young adults. Hypertension 2011, 57:255-260.
26. Parmar H.S., Kar A. Possible amelioration of atherogenic diet induced dyslipidemia, hypothyroidism and hyperglycemia by the peel extracts of Mangifera indica, Cucumis melo and Citrullus vulgaris fruits in rats. Biofactors 2008, 33:13-24.
27. Grundy S.M., Pasternak R., Greenland P., Smith S., Fuster V. AHA/ACC scientific statement: assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 1999, 34:1348-1359.
28. Kuller L.H. Prevention of cardiovascular disease and the future of cardiovascular disease epidemiology. Int J Epidemiol 2001, 30(Suppl. 1):S66-S72.
29. Karalis D.G. Intensive lowering of low-density lipoprotein cholesterol levels for primary prevention of coronary artery disease. Mayo Clin Proc 2009, 84:345-352.
30. Majesky M.W. Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol 2007, 27:1248-1258.
31. Hayashi T., Juliet P.A., Matsui-Hirai H., Miyazaki A., Fukatsu A., Funami J., et al. l-Citrulline and l-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits. Proc Natl Acad Sci USA 2005, 102:13681-13686.
32. El-Kirsh A.A., Abd El-Wahab H.M., Abd-Ellah Sayed H.F. The effect of l-arginine or l-citrulline supplementation on biochemical parameters and the vascular aortic wall in high-fat and high-cholesterol-fed rats. Cell Biochem Funct 2011, 29:414-428.
33. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
34. Abdelwahab S.I., Hassan L.E., Sirat H.M., Yagi S.M., Koko W.S., Mohan S., et al. Anti-inflammatory activities of cucurbitacin E isolated from Citrullus lanatus var. citroides: role of reactive nitrogen species and cyclooxygenase enzyme inhibition. Fitoterapia 2011, 82:1190-1197.